The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Advanced Medicine, Inc.

Advanced Medicine, Inc.
 PROFILE
Advanced Medicine is looking to provide some long-lasting relief -- longer than what's currently available. Targeting not only pain management but also respiratory, urogenital, and infectious diseases, the development-stage firm discovers and develops multivalent small-molecule drug candidates. A multivalent compound can attach to several sites on a biological target, thereby improving such therapeutic properties as duration, potency, or safety. Advanced Medicine also plans to develop drug candidates using its multivalent technology in partnership with other biotech firms.

 COMPETITION
AstraZeneca PLC (AZN)
Axys Pharmaceuticals, Inc. (AXPH)
Endo Pharmaceuticals Holdings, Inc. (ENDP)

 FINANCIAL OVERVIEW
Fiscal Year-End: December
1999 Sales (mil.): 0.00
Employees: 176
Revenue per employee: $0.00

 KEY PEOPLE
• James B. Tananbaum
    CEO
• Marty Glick
    CFO

 CONTACT INFO
901 Gateway Blvd.
South San Francisco, CA 94080
US
Phone: 650-808-6000
Fax: 650-827-8690
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001